Memry Corp

Memry — Westergaard Conference Webcast November 2007

24 slides from Memry's conference presentation, Nov 13, 2007

  1. Slide 1: Westergaard Conference Webcast November 2007

    MIEMRY Westergaard Conference Webcast November 2007

  2. Slide 2: Forward-looking statements

    This presentation contains certain forward-looking statements which involve known and unknown risks, uncertainties or other factors not under the Company’s control which may cause actual results, performance or achievements of the Company to be materially different from the results, performance, or

  3. Slide 3: Compelling Value Proposition

    Compelling Value Proposition Innovative, Strategic Technology Solutions Large and Growing Medical Device Market Strong Growing Pipeline Strong Balance Sheet Strong Cash Generator Building Momentum Trading Near Book Value

  4. Slide 4: Enabling minimally invasive and targeted therapies for the medical industry

    “Enabling minimally invasive and targeted therapies for the medical industry”

  5. Slide 5: Materials & Processes Enabling Properties (Nitinol)

    Materials & Processes Enabling Properties Superelastic & Shape Kink resistance Memory Nitinol Alloys Crush resistance Ability to recover large Wire & Tube Drawing deformation ; Thermal Recovery Laser Cutting Confined Access & Delivery Stent Manufacturing Wire Forming Surface Finishing Grinding & Coa

  6. Slide 6: Materials & Processes Enabling Properties (Polymers)

    Materials & Processes Enabling Properties Custom Co-Extruded Multi Layer Polymer Components Multi Lumen pep aetnenes Coil and Braid Reinforcement hems Thin Wall Polyesters . Fluoropolymers Jacketing Polyimides Radiopacity Tipping & Forming Tapering Grinding Braiding & Coiling Catheter-based Minimall

  7. Slide 7: Surgical Devices & Instruments

    78.3% Surgical Devices & Instruments ™ Orthopaedics Monitoring/Imaging ™ Surgery/Endosurgery Electrosurgical/ Auxiliary Equipment Cardiovascular/Thoracic Robotics (Source: BCC Research, June 2006)

  8. Slide 8: Improving Quality of Healthcare

    Improving Quality of Healthcare Aging Population Stringent Regulatory Environment Competition & Speed to Market External Drivers Cost Containment Product Innovation & Technology Mergers & Acquisitions Globalization Vendor Base Consolidation Millennium Research Group, October 2005

  9. Slide 9: Device OEMs want to focus on R&D, Technology, Sales & Marketing

    Device OEMs want to focus on R&D, Technology, Sales & Marketing, Distribution and Regulatory Issues Device companies outsource for a variety of reasons Reduce operating costs Expand their portfolio of capabilities Simplify supply chain logistics Reduce capital expenditures Larger, full-service suppl

  10. Slide 10: Full Suite of Capabilities

    Full Suite of Capabilities Supply Chain Management Technology Leadership Rapid Turnaround Quality & Competitive Pricing Device Application Knowledge Globalization

  11. Slide 11: Management team

    Robert Belcher, Chief Executive Officer Dean Tulumaris, President & Chief Operating Officer Richard Sowerby, Chief Financial Officer & Treasurer Philippe Poncet, Vice President Business Development Marcy Macdonald, Vice President Human Resources

  12. Slide 12: oF . AR :

    oF . AR :

  13. Slide 13: Orthopedics

  14. Slide 14: Vascular/Radiology

  15. Slide 15: Neurology

    Neurology/ |

  16. Slide 16: Coronary & EP

    Coronary & EP |

  17. Slide 17: Urology/OBGyn

    Urology/OBGyn @ |

  18. Slide 18: Ophthalmology / ENT

    ( a Ophthalmology ENT

  19. Slide 19: Clinical areas served

    Neurology). ) Ophthalmolo: ENT@ug P ay Corénary &EP @ Vas¢ular/Radiglogy ( } | Endosurgery e 74 UrolggyiOBGyn | } | ey Orthopaedics

  20. Slide 20: High-end Processing Technologies

    High-end Processing Technologies Passive and Biointeractive Medical Polymers & Biomaterials Materials, Processes & Product Integration Surface Modification & Finishing Technologies Integration Technologies Critical to Complete Product capability 4 Market Leadership & Recognition as Leading Provider

  21. Slide 21: FY 2007, FY 2006, FY 2005 results

    FY 2007. FY 2006 FY 2005 Revenues $51.7M $52.6M $45.0M Gross Margin 32% 39% 40% Net Income $0.3May. $2.7Ma») $2.7M. Total Debt $1.6 $10.0 $11.4 Debt/Capital 4% 20% 24% a) Includes pre-tax incremental fees for litigation and professional fees for litigation defense and the implementation of Sarbanes-

  22. Slide 22: Consolidated Revenues & Gross Margin

    Consolidated Revenues & Gross Margin By Quarter 2005 - 2008 Revenue

  23. Slide 23: Cash Flow From Operating Activities

    . ee Fiscal Year Three Months Ended ash Flow From Operating Activities: 2006 2007 09/30/06 _ 09/30/07 o A Net income $2.7 $0.3 $1.0 $0.4 Adjustments to reconcile net income to net NN cash provided by operating activities: Depreciation and amortization 2.9 3.2 0.8 Deferred income taxes 1.4 0.2 0.6 St

  24. Slide 24: Compelling Value Proposition

    Compelling Value Proposition Innovative, Strategic Technology Solutions Large and Growing Medical Device Market Strong Growing Pipeline Strong Balance Sheet Strong Cash Generator Building Momentum Trading Near Book Value

Memry — Westergaard Conference Webcast November 2007 on 6ix